Impact of HMG‐CoA reductase inhibitors on the incidence of polyomavirus‐associated nephropathy in renal transplant recipients with human BK polyomavirus viremia

Publisher： John Wiley & Sons Inc

E-ISSN： 1399-3062|17|4|536-543

ISSN： 1398-2273

Source： TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol.17, Iss.4, 2015-08, pp. : 536-543

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human Polyomavirus BK Monitoring by Quantitative PCR in Renal Transplant Recipients

By  

Intervirology, Vol. 47, Iss. 1, 2004-03 ,pp. : 41-47

Karger

Access to resources Recommend Favorite

Falsely decreased ionized calcium levels in kidney transplant recipients with polyomavirus‐associated nephropathy treated with leflunomide

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 7, 2015-07 ,pp. : 874-875

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of low‐level BK polyomavirus viremia on intermediate‐term renal allograft function

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 20, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 18, Iss. 1, 2018-01 ,pp. : 245-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

Conversion to a sirolimus‐based regimen is associated with lower incidence of BK viremia in low‐risk kidney transplant recipients

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 1, 2015-02 ,pp. : 66-72

John Wiley & Sons Inc

Access to resources Recommend Favorite